You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | 5.5% | n/a |
| ROCE | 4.5% |
| Latest | Forecast | |
|---|---|---|
| P/E | 55.1 | n/a |
| PEG | 1.7 | n/a |
| Price / Revenue | 8.5 | n/a |
| Price / Book value | 5.7 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 29.6% | n/a |
| PBT | -43.3% | n/a |
| EPS | 32.3% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | 10.37 | 0.88 | 1.86p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 13.44 | 0.50 | 2.46p | 41.5 | 1.3 | 32% | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|
| Diaceutics shares rise as it launches new diagnostic development platform Sharecast News | 28 Oct |
|---|---|
| Diaceutics wins £1m pharmaceutical client contract Sharecast News | 22 Jul |
| Diaceutics builds on strong Q1, trades in line Sharecast News | 08 Jul |
| Holding(s) in Company | 10-Nov-20 16:32 |
|---|---|
| Commercial launch of DXRX | 28-Oct-20 07:04 |
| Second Price Monitoring Extn | 07-Sep-20 14:07 |
| Price Monitoring Extension | 07-Sep-20 14:02 |
| Price Monitoring Extension | 07-Sep-20 11:01 |